Efficacy and safety of emergent balloon aortic valvuloplasty as a rescue therapy for cardiogenic shock due to severe aortic stenosis in non-TAVI centers.

ABSTRACT:

Background

The prognosis of aortic stenosis (AS) with cardiogenic shock remains poor, and optimal initial treatment remains unclear. Emergent balloon aortic valvuloplasty (BAV) is a treatment option for salvage and recent studies have reported that early release of valve obstruction by emergent BAV could improve prognosis. This study aimed to assess the efficacy and safety of emergent BAV for severe AS with cardiogenic shock.

Methods

Among 8,230 patients hospitalized for heart failure, 7924 patients with heart failure unrelated to severe AS were excluded. Among the remaining 306 patients, 256 patients who developed cardiogenic shock due to other causes except severe AS were further excluded. Finally, a total of 41 patients with severe AS in cardiogenic shock were enrolled an

SUBMITTER: Masuda M 

PROVIDER: S-EPMC12648894 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature